Authors: Matthias an der Heiden, Udo Buchholz, Gérard Krause, Göran Kirchner, Hermann Claus, Walter H. Haas
DOI: 10.1371/journal.pone.0008356
Abstract Summary
Early pandemic control strategies targeting the first 10,000 H1N1 cases through contact tracing, quarantine, and selective prophylactic treatment could delay epidemic peaks by up to 7.6 weeks. While total infection rates remain unchanged, this delay requires minimal antivirals—less than 0.1% of population treatment courses.
Why Brain? 🧠
Study shows early pandemic control measures like contact tracing and targeted antiviral treatment can delay H1N1 epidemic peak by up to 7.6 weeks, buying crucial time for vaccine development.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
